Transforming growth factor-β1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity

British Journal of Haematology

Volumn 118, Issue 2, 2002, Pages 627-637

  Pierelli, Luca ^a   Marone, Maria ^a   Bonanno, Giuseppina ^a   Rutella, Sergio ^a   De Ritis, Daniela ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

CD34; p38 MAP kinase; Stem cells; TGF 1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD34 ANTIGEN; PROTEIN ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RNA; SMAD PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION;

ANTIGENS, CD34; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036040230     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03604.x     Document Type: Article

References (40)

1. TGF-(beta) 1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation
2. Stromal cells retard differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history
3. A newly discovered class of human hematopoietic cells with SCID-repopulating activity
4. Regulation of c-myb expression in ML-1 human myeloblastic leukemia cells by c-ets-1 protein
5. SDF-1 and TGF-β enhance the detection of transplantable human stem cells regenerating in NOD/SCID mice
6. Determinants of specificity in TGF-β signal transduction
7. Hematopoietic defects in mice lacking the sialomucin CD34
8. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
9. Up-regulation of surface CD34 is associated with protein kinase c-mediated hyperphosphorylation of CD34
10. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1
11. Transforming growth factor β: Pleiotropic role in the regulation of hematopoiesis
12. Involvement of the p38 mitogen-activated protein kinase pathway in Transforming growth factor-β-induced gene expression
13. The stem cell antigen Cd34 functions as a regulator of hemopoietic cell adhesion
14. Molecular characterization of CD34+ human hematopoietic progenitor cells
15. CD34: Structure, biology and clinical utility
16. CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb
17. TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2
18. Endoglin modulates cellular responses to TGF-beta 1
19. s expression in normal and neoplastic ovarian tissues
20. Analysis of cyclin E and cdk2 in ovarian cancer: Gene amplification and RNA overexpression
21. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample
22. Transforming growth factor-b1 transcriptionally activates CD34 and prevents induced differentiation TF-1 cells in the absence of any cell-cycle effects
23. The transforming growth factor β family
24. TGF-β signal transduction
25. Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34
26. Regulation of the expression of the hematopoietic stem cell antigen CD34: Role of c-myb
27. TGF-β receptors and signal transduction
28. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocitic, but not monocytic, differentiation
29. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation
30. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3
31. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
32. Ex vivo generation of CD34+ cells from CD34-hematopoietic cells
33. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ hematopoietic progenitors
34. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: Role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin 15
35. Modulation of bcl-2 and p27 in primitive, proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle independent effect and influences their hematopoietic potential
36. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/-precursors
37. A nuclear factor Y (NFY) site positively regulates the human CD34 stem cell gene
38. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase
39. Regulation of the gene for CD34, a human hematopoietic stem cell antigen, in KG-1 cells
40. Monitoring mRNA expression by polymerase chain reaction by the 'primer dropping' method